41 related articles for article (PubMed ID: 24979840)
1. Angioedema without wheals: a clinical update.
Gülbahar O
Balkan Med J; 2021 Mar; 38(2):73-81. PubMed ID: 33593719
[TBL] [Abstract][Full Text] [Related]
2. [Angioedema prophylaxis].
Zampeli V; Magerl M
Hautarzt; 2019 Feb; 70(2):107-115. PubMed ID: 30656382
[TBL] [Abstract][Full Text] [Related]
3. Case report presenting the diagnostic challenges in a patient with recurrent acquired angioedema, antiphospholipid antibodies and undetectable C2 levels.
Bonnin AJ; DeBrosse C; Moncrief T; Richmond GW
Allergy Asthma Clin Immunol; 2018; 14():24. PubMed ID: 29881401
[TBL] [Abstract][Full Text] [Related]
4. Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder.
Agyemang E; Bailey L; Talbot J
Pharmaceut Med; 2017; 31(2):101-112. PubMed ID: 28413313
[TBL] [Abstract][Full Text] [Related]
5. A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.
Gobert D; Paule R; Ponard D; Levy P; Frémeaux-Bacchi V; Bouillet L; Boccon-Gibod I; Drouet C; Gayet S; Launay D; Martin L; Mekinian A; Leblond V; Fain O
Medicine (Baltimore); 2016 Aug; 95(33):e4363. PubMed ID: 27537564
[TBL] [Abstract][Full Text] [Related]
6. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
Cicardi M; Zanichelli A
Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
[TBL] [Abstract][Full Text] [Related]
7. New perspectives in acquired angioedema.
Kivity S
Isr Med Assoc J; 2014 May; 16(5):313-4. PubMed ID: 24979839
[No Abstract] [Full Text] [Related]
8. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
[No Abstract] [Full Text] [Related]
9. Lymphoproliferative disease and acquired C1 inhibitor deficiency.
Castelli R; Deliliers DL; Zingale LC; Pogliani EM; Cicardi M
Haematologica; 2007 May; 92(5):716-8. PubMed ID: 17488706
[TBL] [Abstract][Full Text] [Related]
10. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
11. Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers.
Dreyfus DH; Na CR; Randolph CC; Kearney D; Price C; Podell D
Isr Med Assoc J; 2014 May; 16(5):315-6. PubMed ID: 24979840
[No Abstract] [Full Text] [Related]
12. Acquired angioedema responding to rituximab.
Hassan A; Amarger S; Tridon A; Ponard D; Souteyrand P; D'Incan M
Acta Derm Venereol; 2011 Oct; 91(6):733-4. PubMed ID: 21691703
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
